| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO &SVP, Finance | Chief Financial Officer &SVP
3 companies
Roberts Brandi is a Chief Financial Officer at Definium Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 1 sell.
Estimated insider holdings value: $9.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | DFTX Definium Therapeutics, Inc. | Chief Financial Officer | Sell | 3,013 | $45.03 | $135,675.39 | -1.4% | - | - | |
| Aug 13, 2019 | LCTX Lineage Cell Therapeutics, Inc. | CFO &SVP, Finance | Buy | 5,000 | $1.01 | $5,050.00 | New | - | - | |
| Mar 27, 2015 | SVRA Savara Inc | Chief Financial Officer &SVP | Buy | 38,000 | $0.50 | $18,981.60 | +190.0% | - | - |